Stocks · News reference
Keefe, Bruyette & Woods analyst Paul Johnson downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Market Perform and lowers the price target from $13 to $12.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
WALL analysts changed outlook on top names. See upgrades, downgrades & initiations on analyst ratings page. Workday downgraded, price target cut.
Read original at benzingaLadenburg Thalmann analyst Christopher Nolan maintains Crescent Capital BDC (NASDAQ:CCAP) with a Buy and lowers the price target from $15 to $14.
Read original at benzingaB. Riley Securities analyst Sean-Paul Adams maintains Crescent Capital BDC (NASDAQ:CCAP) with a Neutral and lowers the price target from $13.5 to $12.5.
Read original at benzinga